Ikram Elayan

870 total citations
17 papers, 654 citations indexed

About

Ikram Elayan is a scholar working on Pediatrics, Perinatology and Child Health, Small Animals and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ikram Elayan has authored 17 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Small Animals and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ikram Elayan's work include Animal testing and alternatives (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Pharmaceutical studies and practices (4 papers). Ikram Elayan is often cited by papers focused on Animal testing and alternatives (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Pharmaceutical studies and practices (4 papers). Ikram Elayan collaborates with scholars based in United States and Thailand. Ikram Elayan's co-authors include W. W. Winder, Charles Auker, Milton J. Axley, Stephen T. Ahlers, Paruchuri V. Prasad, Hyun Kyoon Lim, James W. Gibb, Glen R. Hanson, Pat R. Vehrs and Michel Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Journal of Neurophysiology.

In The Last Decade

Ikram Elayan

16 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ikram Elayan United States 13 194 191 124 124 69 17 654
Russell Bialecki United States 19 391 2.0× 235 1.2× 173 1.4× 65 0.5× 15 0.2× 38 884
Yan Chang China 16 223 1.1× 116 0.6× 77 0.6× 31 0.3× 31 0.4× 36 938
John F. Reed United States 14 228 1.2× 122 0.6× 238 1.9× 35 0.3× 165 2.4× 18 752
Philip G. Baer United States 17 367 1.9× 166 0.9× 40 0.3× 26 0.2× 17 0.2× 47 1.2k
Vidar M. Steen Norway 14 354 1.8× 106 0.6× 96 0.8× 30 0.2× 4 0.1× 25 969
Walter Osswald Portugal 17 360 1.9× 263 1.4× 291 2.3× 18 0.1× 28 0.4× 83 920
Simon H. Ridley United Kingdom 7 193 1.0× 105 0.5× 62 0.5× 24 0.2× 8 0.1× 10 643
Jonathan Bullman United Kingdom 14 118 0.6× 267 1.4× 118 1.0× 10 0.1× 29 0.4× 22 640
Afonso Caricati‐Neto Brazil 16 351 1.8× 146 0.8× 146 1.2× 20 0.2× 10 0.1× 98 945
Sydney Ellis United States 16 251 1.3× 204 1.1× 112 0.9× 50 0.4× 10 0.1× 47 782

Countries citing papers authored by Ikram Elayan

Since Specialization
Citations

This map shows the geographic impact of Ikram Elayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikram Elayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikram Elayan more than expected).

Fields of papers citing papers by Ikram Elayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikram Elayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikram Elayan. The network helps show where Ikram Elayan may publish in the future.

Co-authorship network of co-authors of Ikram Elayan

This figure shows the co-authorship network connecting the top 25 collaborators of Ikram Elayan. A scholar is included among the top collaborators of Ikram Elayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikram Elayan. Ikram Elayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Morris, Patrick J., Richard Burke, Alok Sharma, et al.. (2021). A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801. Neurotoxicology and Teratology. 87. 106993–106993. 18 indexed citations
2.
Bonzo, Jessica A., Todd Bourcier, Ikram Elayan, et al.. (2020). An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regulatory Toxicology and Pharmacology. 114. 104662–104662. 112 indexed citations
3.
Fisher, J. Edward, Arippa Ravindran, & Ikram Elayan. (2019). CDER Experience With Juvenile Animal Studies for CNS Drugs. International Journal of Toxicology. 38(2). 88–95. 13 indexed citations
4.
Aungst, Jason, Federica Basso, Karen Davis‐Bruno, et al.. (2018). Utility of generational developmental and reproductive toxicity and juvenile animal study protocols for the infant safety assessment of food contact materials. SHILAP Revista de lepidopterología. 2.
5.
Anderson, J, et al.. (2017). Effects of Cyclophosphamide and/or Doxorubicin in a Murine Model of Postchemotherapy Cognitive Impairment. Toxicological Sciences. 162(2). 462–474. 31 indexed citations
6.
Henck, Judith, Ikram Elayan, Charles V. Vorhees, J. Edward Fisher, & LaRonda L. Morford. (2016). Current Topics in Postnatal Behavioral Testing. International Journal of Toxicology. 35(5). 499–520. 4 indexed citations
7.
Papoian, Thomas, Haw-Jyh Chiu, Ikram Elayan, et al.. (2015). Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective. Nature Reviews Drug Discovery. 14(4). 294–294. 47 indexed citations
8.
Tassinari, Melissa S., Kimberly Benson, Ikram Elayan, Parvaneh Espandiari, & Karen Davis‐Bruno. (2011). Juvenile animal studies and pediatric drug development retrospective review: use in regulatory decisions and labeling. Birth Defects Research Part B Developmental and Reproductive Toxicology. 92(4). n/a–n/a. 20 indexed citations
9.
Elayan, Ikram, Milton J. Axley, Paruchuri V. Prasad, Stephen T. Ahlers, & Charles Auker. (2000). Effect of Hyperbaric Oxygen Treatment on Nitric Oxide and Oxygen Free Radicals in Rat Brain. Journal of Neurophysiology. 83(4). 2022–2029. 124 indexed citations
10.
Gibb, James W., Michel Johnson, Ikram Elayan, et al.. (1997). Neurotoxicity of Amphetamines and Their Metabolites. PsycEXTRA Dataset. 173. 128–45. 26 indexed citations
11.
Elayan, Ikram, James W. Gibb, Glen R. Hanson, et al.. (1993). Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 813–818. 7 indexed citations
12.
Johnson, Michel, Ikram Elayan, Glen R. Hanson, et al.. (1992). Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.. Journal of Pharmacology and Experimental Therapeutics. 261(2). 447–453. 51 indexed citations
13.
14.
Elayan, Ikram, et al.. (1991). Malonyl-CoA in Skeletal Muscle and Liver of Streptozotocin-Diabetic Rats. Experimental Biology and Medicine. 198(1). 569–571. 5 indexed citations
15.
Elayan, Ikram & W. W. Winder. (1991). Effect of glucose infusion on muscle malonyl-CoA during exercise. Journal of Applied Physiology. 70(4). 1495–1499. 33 indexed citations
16.
Winder, W. W., et al.. (1990). Time course of exercise-induced decline in malonyl-CoA in different muscle types. American Journal of Physiology-Endocrinology and Metabolism. 259(2). E266–E271. 69 indexed citations
17.
Winder, W. W., et al.. (1989). Muscle malonyl-CoA decreases during exercise. Journal of Applied Physiology. 67(6). 2230–2233. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell Bialecki Breakdown of academic impact, for papers by Yan Chang Breakdown of academic impact, for papers by John F. Reed Breakdown of academic impact, for papers by Philip G. Baer Breakdown of academic impact, for papers by Vidar M. Steen Breakdown of academic impact, for papers by Walter Osswald Breakdown of academic impact, for papers by Simon H. Ridley Breakdown of academic impact, for papers by Jonathan Bullman Breakdown of academic impact, for papers by Afonso Caricati‐Neto Breakdown of academic impact, for papers by Sydney Ellis
Rankless by CCL
2026